| Literature DB >> 22577529 |
Maryam Barzin1, Farhad Hosseinpanah, Hamidreza Saber, Parvin Sarbakhsh, Kobra Nakhoda, Fereidoun Azizi.
Abstract
Aims. To investigate the trend of metabolic syndrome and its components in Tehran children and adolescents during a median followup of 6.6 years. Methods. Data from 1999-2001 (phase I), 2002-2005 (phase II), and 2006-2008 (phase III) of the Tehran, Lipid and Glucose Study were analyzed (n = 5439; age 6-18 years) for the trend of metabolic syndrome (MetS) and its components. General estimation equation (GEE) models were used to analyze this correlated data. Results. The crude prevalence of MetS for boys at baseline was 13.2%, which increased to 16.4% in the third phase. In girls, the prevalence of Mets decreased from 11.8% at baseline to 6% during followup. The odd ratios (OR) of obesity over the whole study period were raised in both sexes. The OR of abdominal obesity increased significantly in boys, but no change was observed in girls. No significant OR was observed in boys, while OR for MetS was shown to have a decreasing trend in girls during the followup. In the three time points, the ORs of MetS decreased significantly in girls but no significant difference was observed in boys. Conclusion. Inspite of increasing trend for obesity in both sexes, the trend of MetS decreased in girls and was relatively stable in boys, in Tehranian children, and adolescents.Entities:
Year: 2012 PMID: 22577529 PMCID: PMC3345209 DOI: 10.1155/2012/804643
Source DB: PubMed Journal: Cholesterol ISSN: 2090-1283
Anthropometric and metabolic characteristics of cohort participants by sex in 3 phases.
| Phase I | Phase II | Phase III | ||||
|---|---|---|---|---|---|---|
| Boys | Girls | Boys | Girls | Boys | Girls | |
| Age (year) | 12.5 ± 3.5 | 12.6 ± 3.6 | 14.2 ± 4.53 | 14.7 ± 4.5 | 16.0 ± 5.6 | 16.6 ± 5.4 |
| Weight (kg) | 44.7 ± 19.2 | 42.7 ± 15.56* | 53.1 ± 21.8 | 48.2 ± 16.0* | 59.3 ± 23.6 | 51.4 ± 15.7* |
| BMI (kg/m²) | 18.9 ± 4.4 | 19.0 ± 4.5 | 20.6 ± 5.0 | 20.6 ± 4.5 | 22.0 ± 6.3 | 21.4 ± 4.6* |
| Overweight (%) | 19.7 | 17.5 | 28.3 | 23.7* | 34.3 | 27.2* |
| Obesity (%) | 8.3 | 6* | 11.9 | 8.4* | 13.8 | 8.9* |
| WC (cm) | 65.0 ± 12.5 | 65.7 ± 10.8* | 73.6 ± 14.6 | 69.0 ± 11.3* | 77.8 ± 15.8 | 69.2 ± 11.0* |
| Abdominal obesity (%) | 12.3 | 13.7 | 26.9 | 14.3* | 33.1 | 13* |
| SBP (mmHg) | 106.2 ± 12.2 | 103.6 ± 11.3* | 104.0 ± 13.0 | 98.8 ± 11.3* | 104.6 ± 13.2 | 98.3 ± 11.3* |
| DBP (mmHg) | 71.1 ± 9.5 | 71.2 ± 9.4 | 67.2 ± 10.0 | 67.2 ± 9.4 | 67.5 ± 10.5 | 64.7 ± 9.6* |
| FBG (mg/dL) | 88.9 ± 11.3 | 86.9 ± 8.3* | 88.7 ± 11.6 | 86.2 ± 7.4* | 86.9 ± 7.5 | 84.7 ± 7.0* |
| TG (mg/dL) | 103.7 ± 60. 7 | 107.9 ± 54.9* | 101.6 ± 54.4 | 99.0 ± 47.7 | 105.2 ± 61.4 | 94.6 ± 45.9* |
| HDL-C (mg/dL) | 44.0 ± 10.8 | 44.0 ± 10.5 | 40.8 ± 10.3 | 41.5 ± 10.1 | 42.8 ± 10.3 | 45.6 ± 10.4* |
Data are presented as mean (SD) or percent.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglycerides HDL-C, high density lipoprotein cholesterol. Overweight defined as ≥85th to <95th percentile of BMI for age and sex; obesity defined as ≥95th percentile of BMI for age and sex; abdominal obesity defined as WC ≥ 90th percentile for age and sex.
*P < 0.001 (between boys and girls in each phase).
Figure 1Prevalence of metabolic syndrome (MetS) and its components in boys (n = 2643) and girls (n = 2797). Obesity defined as ≥95th percentile of BMI for age and sex; high waist circumference (H-WC) ≥90th percentile for age and sex, according to national reference curves; high blood pressure (H-BP), SBP and/or DBP ≥90th percentile for sex, age and height, from national reference cut-off points; high fasting blood glucose (H-FBG), fasting glucose ≥100 mg/dL; high triglycerides (H-TG), fasting TG ≥ 110 mg/dL; low HDL cholesterol (L-HDL), HDL < 40 mg/dL.
Odd ratiosa of the incident MetS parameters in phase I, II and III.
| Characteristics | phase I | phase II | phase III |
|---|---|---|---|
| Boys | |||
| obesity | 1 | 1.40 (1.16–1.68)* | 1.49 (1.19–1.87)* |
| Abdominal obesity | 1 | 2.28 (1.95–2.67)* | 2.61 (2.19–3.12)* |
| High FBG | 1 | 0.90 (0.69–1.18) | 0.47 (0.34–0.64)* |
| Low HDL-C | 1 | 1.51 (1.32–1.73)* | 0.84 (0.73–0.96)* |
| High TG | 1 | 0.68 (0.58–0.78)* | 0.63 (0.54–0.74)* |
| High BP | 1 | 0.45 (0.37–0.53)* | 0.42 (0.34–0.52)* |
| MetS | 1 | 1.1 (0.90–1.33) | 0.94 (0.73–1.22) |
|
| |||
| Girls | |||
| obesity | 1 | 1.42 (1.14–1.77)* | 1.41 (1.07–1.84)* |
| Abdominal obesity | 1 | 1.08 (0.912–1.28) | 0.98 (0.79–1.21) |
| High FBG | 1 | 0.78 (0.56–1.08) | 0.59 (0.42–0.83)* |
| Low HDL-C | 1 | 1.89 (1.66–2.14)* | 1.07 (0.93–1.22) |
| High TG | 1 | 0.65 (0.67–0.75)* | 0.50 (0.43–0.58)* |
| High BP | 1 | 0.50 (0.43–0.58)* | 0.21 (0.16–0.27)* |
| MetS | 1 | 0.21 (0.16–0.27)* | 0.55 (0.41–0.75)* |
Obesity, BMI ≥ 95th percentile for age and sex; abdominal obesity, WC ≥ 90th percentile for age and sex; high FBG, FBS ≥ 100 (mg/dL); Low HDL-C, HDL-C < 40 (mg/dL); high TG, TG ≥ 110 (mg/dL); High BP, SBP, and/or DBP ≥90th percentile for sex, age, and height.
a(95% Confidence interval).
*P value <0.05 compare to phase I.